Vol 13, No 1 (January 31, 2024): Translational Lung Cancer Research

Editorial

Current opportunities and challenges in ALK-positive lung cancer
Jessica J. Lin, Justin F. Gainor
Translational Lung Cancer Research  
2024;
13
(1)
:1-4
.

Original Article

Expression of cytokines in pleural effusions and corresponding cell lines of small cell lung cancer
Barbara Rath, Sandra Stickler, Maximilian J. Hochmair, Gerhard Hamilton
Translational Lung Cancer Research  
2024;
13
(1)
:5-15
.
Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center
Ao Zeng, Yicheng Xiong, Jing Zhang, Huansha Yu, Lele Zhang, Dongliang Bian, Lu Han, Jue Wang, Yan Chen, Mohammed Saud Shaik, Peng Zhang, Jie Dai
Translational Lung Cancer Research  
2024;
13
(1)
:16-33
.
In-depth proteomic analysis identifies key gene signatures predicting therapeutic efficacy of anti-PD-1/PD-L1 monotherapy in non-small cell lung cancer
Xiaoshen Zhang, Guanghui Gao, Qian Zhang, Songchen Zhao, Xuefei Li, Wei Cao, Heng Luo, Caicun Zhou
Translational Lung Cancer Research  
2024;
13
(1)
:34-45
.
Clinical and financial impact of immune checkpoint inhibitors following platinum chemotherapy in patients with advanced or metastatic non-small cell lung cancer: a nationwide population-based study
Hyun Woo Ji, Sungyoun Chun, Jung Mo Lee, Seon Cheol Park, Chang Hoon Han, Chi Young Kim, Sang Chul Lee
Translational Lung Cancer Research  
2024;
13
(1)
:46-59
.
Bronchoscopic deployment and implantation of Diffusing alpha-emitters Radiation Therapy into the lung and mediastinum for treatment of lung cancer: a pre-clinical safety and feasibility study
Ali Sadoughi, Abhishek Sarkar, Carol Novotney, Christine Chan, Gerardo Moreno, Stephanie Oren, Lior Moss, Kobi Aharoni, Saleem Eben Bari, Nir Edery, Nitin Ohri
Translational Lung Cancer Research  
2024;
13
(1)
:60-75
.
Racial disparities in staging, treatment, and mortality in non-small cell lung cancer
Francesca C. Duncan, Nawar Al Nasrallah, Lauren Nephew, Yan Han, Andrew Killion, Hao Liu, Ahmad Al-Hader, Catherine R. Sears
Translational Lung Cancer Research  
2024;
13
(1)
:76-94
.
Nomogram for predicting prognosis and identifying chemotherapy beneficiaries for completely resected stage I invasive mucinous lung adenocarcinoma
Hua He, Xiaofei Zeng, Quan Zhang, Wenteng Hu, Rongfei Huang, Hongxin Zhao, Shuo Sun, Ruijiang Lin, Peng Yue, Biao Han, Minjie Ma, Chang Chen
Translational Lung Cancer Research  
2024;
13
(1)
:95-111
.
Machine learning model for circulating tumor DNA detection in chronic obstructive pulmonary disease patients with lung cancer
Sun Hye Shin, Soojin Cha, Ho Yun Lee, Seung-Ho Shin, Yeon Jeong Kim, Donghyun Park, Kyung Yeon Han, You Jin Oh, Woong-Yang Park, Myung-Ju Ahn, Hojoong Kim, Hong-Hee Won, Hye Yun Park
Translational Lung Cancer Research  
2024;
13
(1)
:112-125
.
Potential synergistic effects of cranial radiotherapy and atezolizumab in non-small cell lung cancer: an analysis of individual patient data from seven prospective trials
Tiantian Guo, Yue Zhou, Fei Liang, Zezhou Wang, Vincent Bourbonne, Lukas Käsmann, Nora Sundahl, Abraham Jing-Ching Wu, Jianjiao Ni, Zhengfei Zhu
Translational Lung Cancer Research  
2024;
13
(1)
:126-138
.
Real-world incidence and risk factors of pneumonitis in chemoradiation plus immune checkpoint inhibitors compared with chemoradiation alone in lung cancer: a retrospective cohort study
Dan Pu, Qing Liu, Shu Zhang, Liu Wang, Feng Xu, Paul Hofman, Raffaele Giusti, Qinghua Zhou, Xuehan Li, Lu Li
Translational Lung Cancer Research  
2024;
13
(1)
:139-151
.
Alectinib continuation beyond progression in ALK-positive non-small cell lung cancer with alectinib-refractory
Yimeng Li, Zhanpeng Hao, Yuyan Ma, Kaidiriye Setiwalidi, Yingming Zhang, Yujia Zhao, Xiao Fu, Xuan Liang, Zhiping Ruan, Tao Tian, Yu Yao
Translational Lung Cancer Research  
2024;
13
(1)
:152-162
.

Case Report

Non-bacterial thrombotic endocarditis in ROS1-rearranged lung cancer: a report of two cases
Jordi Recuero-Borau, Laura Masfarré, Nil Navarro, Pedro Rocha, Álvaro Taus, Edurne Arriola
Translational Lung Cancer Research  
2024;
13
(1)
:179-185
.

Editorial Commentary

PD-1 expression on tumor cells: a new target for cancer therapy
Mari Tone, Kota Iwahori
Translational Lung Cancer Research  
2024;
13
(1)
:186-189
.
Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer
Virginia Corbett, Triparna Sen, Aman Chauhan
Translational Lung Cancer Research  
2024;
13
(1)
:190-194
.
Subtype of EGFR exon 19 deletion mutations
Nobukazu Fujimoto
Translational Lung Cancer Research  
2024;
13
(1)
:195-198
.
PI4K2A: a novel potential therapeutic target for lung cancer
Camila Machado Baldavira, Tabatha Gutierrez Prieto, Maria Aparecida Nagai, Vera Luiza Capelozzi
Translational Lung Cancer Research  
2024;
13
(1)
:199-204
.
Will perioperative pembrolizumab treatment change perioperative treatment strategies for resectable non-small cell lung cancer?
Shuji Murakami
Translational Lung Cancer Research  
2024;
13
(1)
:205-209
.

Letter to the Editor

Biomarkers: a new frontier in lung cancer detection
Jehron Pura-Bryant, Justin A. Olivera, Mara B. Antonoff
Translational Lung Cancer Research  
2024;
13
(1)
:210-212
.
Biomarkers as a tool to reduce disparities in lung cancer screening and detection
Edward K. H. Stephens, Jazmin Guayco Sigcha, Kenneth Lopez-Loo, Ian A. Yang, Henry M. Marshall, Kwun M. Fong
Translational Lung Cancer Research  
2024;
13
(1)
:213-214
.